119 related articles for article (PubMed ID: 18937319)
1. Treatment of a CNS relapse while on therapy for Burkitt lymphoma.
Burke MJ; Dayton V
Pediatr Blood Cancer; 2009 Feb; 52(2):290-2. PubMed ID: 18937319
[TBL] [Abstract][Full Text] [Related]
2. Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.
Baleydier F; Pondarre C; Pages MP; Mialou V; Kebaili K; Pracros JP; Bertrand Y
J Pediatr Hematol Oncol; 2008 Dec; 30(12):972-5. PubMed ID: 19131795
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.
Sakarou M; Eisele L; Dührsen U; Hüttmann A
Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system-directed preventative therapy in adults with lymphoma.
McMillan A
Br J Haematol; 2005 Oct; 131(1):13-21. PubMed ID: 16173958
[TBL] [Abstract][Full Text] [Related]
5. Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma.
Segot A; Raffoux E; Lengline E; Thieblemont C; Dombret H; Boissel N; Cluzeau T
Ann Hematol; 2015 Nov; 94(11):1859-63. PubMed ID: 26280395
[TBL] [Abstract][Full Text] [Related]
6. Sporadic paediatric and adult Burkitt lymphomas share similar phenotypic and genotypic features.
Chuang SS; Huang WT; Hsieh PP; Jung YC; Ye H; Du MQ; Lu CL; Cho CY; Hsiao SC; Hsu YH; Lin KJ
Histopathology; 2008 Mar; 52(4):427-35. PubMed ID: 18315595
[TBL] [Abstract][Full Text] [Related]
7. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
Lee KW; Yi J; Choi IS; Kim JH; Bang SM; Kim DW; Im SA; Kim TY; Yoon SS; Lee JS; Bang YJ; Park S; Kim BK; Cho HI; Heo DS
Ann Hematol; 2009 Sep; 88(9):829-38. PubMed ID: 19172274
[TBL] [Abstract][Full Text] [Related]
9. Burkitt lymphoma involving the clivus.
Aronson PL; Reilly A; Paessler M; Kersun LS
J Pediatr Hematol Oncol; 2008 Apr; 30(4):320-1. PubMed ID: 18391704
[TBL] [Abstract][Full Text] [Related]
10. CNS prophylaxis in lymphoma: who to target and what therapy to use.
Hill QA; Owen RG
Blood Rev; 2006 Nov; 20(6):319-32. PubMed ID: 16884838
[TBL] [Abstract][Full Text] [Related]
11. Changing pattern of residual tumor in Burkitt lymphoma: findings at autopsy.
Templeton AC
Arch Pathol Lab Med; 1976 Sep; 100(9):503-5. PubMed ID: 988995
[TBL] [Abstract][Full Text] [Related]
12. [High-dose therapy of Burkitt's lymphoma in patients over 40 years of age].
Kravchenko SK; Bariakh EA; Zamiatina VI; Perestoronina TN; Fink OS; Gubkin AV; Egorova EK; Zvonkov EE; Iliushkina EA; Krasil'nikova BB; Morozova AK; Vorob'ev IA; Kaplanskaia IB; Kliasova GA; Obukhova TN; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2008; 80(7):9-18. PubMed ID: 18763588
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of primary central nervous system lymphoma in the immunocompetent patient].
Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K
Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
Grodman H; Wolfe L; Kretschmar C
Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417
[TBL] [Abstract][Full Text] [Related]
15. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases.
Oh SY; Kim WS; Kim SJ; Kim JS; Kim SH; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Kim JG; Yang DH; Kang HJ; Choi CW; Park J; Choi YJ; Kim HJ; Kwon JH; Suh C; Kim HJ
Am J Hematol; 2009 Dec; 84(12):826-9. PubMed ID: 19890833
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection.
Orem J; Maganda A; Mbidde EK; Weiderpass E
Pediatr Blood Cancer; 2009 Apr; 52(4):455-8. PubMed ID: 18802952
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
[TBL] [Abstract][Full Text] [Related]
18. Toothache, paresthesia, and Horner syndrome: an unusual presentation of disseminated Burkitt's lymphoma.
Nissenbaum M; Kaban LB; Troulis MJ
J Oral Maxillofac Surg; 2007 Jul; 65(7):1395-401. PubMed ID: 17577512
[No Abstract] [Full Text] [Related]
19. Patient compliance in the treatment of Burkitt's lymphoma in rural Zambia: a retrospective study on 80 Burkitt's lymphoma patients in Katete, Zambia.
De Boer JD; Boellaard TN; Parkinson S; Blanchard E; Heij HA
Afr J Paediatr Surg; 2009; 6(1):3-6. PubMed ID: 19661656
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
